Human T-Cell Leukaemia Virus Type 1-Associated Myelopathy in Patients with Rheumatoid Arthritis: A Case Series Highlighting Functional Disability and Diagnostic Challenges

Clicks: 30
ID: 331539
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #44 of 54 articles by views in modern rheumatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
OBJECTIVES: Although rheumatoid arthritis (RA) and human T-cell leukaemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) occasionally coexist, their clinical characteristics and impact on patient outcomes remain poorly elucidated. METHODS: We conducted a retrospective case series of five patients with RA complicated by HAM/TSP (HAM-RA) enrolled in the HTLV-1 Positive Rheumatoid Arthritis Miyazaki Registry. Data on clinical characteristics, disease course, functional status, quality of life and HTLV-1-associated parameters were reviewed. Age- and sex-matched patients with HTLV-1-positive RA and HTLV-1-negative RA served as comparison groups. RESULTS: All patients were women, (median age, 67 years). HAM/TSP preceded RA onset in two patients, whereas RA developed first in three. Neurological disability substantially differed, with Osame Motor Disability Scores of 2-11; three patients necessitated wheelchair use. Despite comparable RA disease activity, patients with HAM-RA demonstrated worse physical function and health-related quality of life than matched controls. Patients with HAM-RA tended to have higher HTLV-1 proviral loads (PVLs) than those with HTLV-1-positive RA without HAM/TSP. CONCLUSIONS: HAM/TSP may develop before or after RA onset and cause substantial functional disability despite satisfactory control of arthritis. Knowledge of HTLV-1 infection status may facilitate consideration of HAM/TSP and timely neurological evaluation. Considering the high PVL in patients with HAM-RA and its association with elevated adult T-cell leukaemia/lymphoma (ATL) risk, cautious long-term monitoring for ATL development may be warranted.
Reference Key
openalex_W7220406266 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal modern rheumatology
Year 2026
DOI
10.1093/mr/roag087
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.